Levorphanol as a Second Line Opioid in Reducing Pain in Patients With Cancer

NCT03579446 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

43

Enrollment

OTHER

Sponsor class

Stopped \<75% participation

Conditions

Hematopoietic and Lymphoid Cell Neoplasm
Malignant Solid Neoplasm
Metastatic Malignant Solid Neoplasm

Interventions

DRUG: Hydrocodone
DRUG: Hydromorphone
DRUG: Levorphanol
DRUG: Morphine
DRUG: Oxycodone
DRUG: Oxymorphone
OTHER: Questionnaire Administration

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]